BEXAROTENE CIPLA 75 mg, soft capsule 100 capsules
Active ingredients: Bexarotene
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BEXAROTENE CIPLA 75 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 100 capsules
- Marketing authorisation holder
- CIPLA EUROPE (BELGIQUE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65407392CIP73024117CIP133400930241172Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BEXAROTÈNEcapsule | 75 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.